A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC
A phase 3 trial of Carboplatin in non-small-cell lung cancer and small-cell lung cancer, run by Jiangsu HengRui Medicine Co., Ltd., now recruiting.
Overview
A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC is a phase 3 interventional study registered as NCT04316364 by Jiangsu HengRui Medicine Co., Ltd., with 537 participants planned, started 2020-07-14 and due to reach its primary completion in 2023-04-15. Interventions recorded: SHR-1316、Paclitaxel (Albumin Bound)、Carboplatin, SHR-1316、Chemotherapeutic, Placebo、Chemotherapeutic. Conditions listed: Non-Small-Cell Lung Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
Shares Jiangsu Hengrui Pharmaceuticals, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialPhase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Adva
Shares Jiangsu Hengrui Pharmaceuticals, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer
Shares Jiangsu Hengrui Pharmaceuticals, Non-small-cell lung cancer.
- TrialA Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations
Shares Jiangsu Hengrui Pharmaceuticals, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Shares Jiangsu Hengrui Pharmaceuticals, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Shares Jiangsu Hengrui Pharmaceuticals, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialPhase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects
Shares Jiangsu Hengrui Pharmaceuticals, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
Shares Jiangsu Hengrui Pharmaceuticals, Small-cell lung cancer, Non-small-cell lung cancer.